Medtronic unveils Endeavor Sprint drug eluting stent on a rapid exchange
Medtronic, Inc. has launched the Endeavor Sprint drug eluting stent (DES) on a rapid exchange (RX) delivery system in the U.S. The Endeavor Sprint system uses Sprinter ™ balloon catheter technology. The system puts the highly deliverable Endeavor DES on an enhanced delivery platform. This makes Medtronic’s flagship DES even easier for physicians to deliver to the site of coronary blockages. The Endeavor Sprint drug eluting stent system is the latest innovation to come out of our robust product pipeline in CardioVascular.
-
Cypher(R) Stent Beats Endeavor(R) in Recent Trial
Medtronic Announces First European Implant Of New Drug-Eluting Stent At Southampton General Hospital, UK
XIENCE V Everolimus Eluting stent more effective than TAXUS Paclitaxel-Eluting stent
Abbott’s XIENCE V(R) Approved In Japan – Second Largest Drug Eluting Stent Market Worldwide
Medtronic Launches Sprinter(R) Angioplasty Balloon Cathethers On Rapid Exchange
